Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 24.39 | N/A |
| PEG Ratio (TTM) | -0.43 | N/A |
| P/S Ratio (TTM) | 1.99 | N/A |
| P/B Ratio (TTM) | 1.09 | N/A |
| P/FCF Ratio (TTM) | 10.59 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.39 | N/A |
| Price to 5YR AVG FCF Ratio | 11.29 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.45% | N/A |
| ROE (TTM) | 4.45% | N/A |
| Net Profit Margin (TTM) | 8.13% | N/A |
| ROIC 5YR AVG | 15.04% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -71.14% | 46.59% | 39.44% |
| Revenue | 11.28% | 16.09% | 25.38% |
| Net Income | -70.98% | 50.83% | 42.57% |
| Cash Flow | -15.21% | 18.43% | 26.10% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.35 | N/A |
| Quick Ratio (TTM) | 0.35 | N/A |
| D/E Ratio (TTM) | 0.28 | N/A |
| Interest Coverage (TTM) | 6.04 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 59.24 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.40% | N/A |